Combined Efficacy of Adrenal Vein Sampling and Imaging Findings in Predicting Clinical Outcomes Following Unilateral Adrenalectomy for Primary Aldosteronism

Abstract

The objective of this study was to investigate the combined efficacy of adrenal vein sampling (AVS) and imaging findings in predicting successful clinical outcomes following unilateral adrenalectomy for primary aldosteronism (PA). A retrospective chart review of 137 patients who underwent AVS between 2009 and 2014 at two hospitals in a single academic institution was performed. Preprocedure demographic, imaging, medication, and laboratory values were reviewed. In general, patients were considered for adrenalectomy when lateralization was suggested on AVS. Clinical outcomes such as improved blood pressure control and preserved renal function after adrenalectomy were correlated with preprocedure variables. AVS was technically successful in 120 out of 137 patients. Lateralization was seen in 64 patients and 48 out of 64 patients underwent adrenalectomy. Out of 48, 43 patients had an adrenal nodule on preoperative imaging, while 5 did not. 28 patients showed improvement in blood pressure after adrenalectomy, all of which had a nodule on imaging. Of the 28 patients, 22 also showed preservation of renal function. None of the remaining 5 (out of 48) patients who demonstrated lateralization on AVS and had no nodule on imaging showed clinical improvement following adrenalectomy. The presence of an adrenal nodule on preoperative imaging was also associated with improved blood pressure control (p = 0.022) and preserved renal function (p = 0.048) following adrenalectomy. Improved blood pressure control and preserved renal function in patients with PA who underwent adrenalectomy following lateralization on AVS are associated with the identification of an adrenal nodule on preoperative imaging.

Keywords

adrenal vein sampling - primary aldosteronism - adrenalectomy

• References

• 1 Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC. Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization. N Engl J Med 1967; 277 (20) 1050-1056
• 2 Mulatero P, Monticone S, Bertello C. , et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 2013; 98 (12) 4826-4833
• 3 Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 2013; 62 (02) 331-336
• 4 Sechi LA, Novello M, Lapenna R. , et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295 (22) 2638-2645
• 5 Reincke M, Rump LC, Quinkler M. , et al; Participants of German Conn's Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2009; 94 (03) 869-875
• 6 Burshteyn M, Cohen DL, Fraker DL, Trerotola SO. Adrenal venous sampling for primary hyperaldosteronism in patients with concurrent chronic kidney disease. J Vasc Interv Radiol 2013; 24 (05) 726-733
• 7 Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 2005; 71 (10) 864-869
• 8 Rossi GP, Bolognesi M, Rizzoni D. , et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008; 51 (05) 1366-1371
• 9 Wang W, Hu W, Zhang X, Wang B, Bin C, Huang H. Predictors of successful outcome after adrenalectomy for primary aldosteronism. Int Surg 2012; 97 (02) 104-111
• 10 Pirvu A, Naem N, Baguet JP, Thony F, Chabre O, Chaffanjon P. Is adrenal venous sampling mandatory before surgical decision in case of primary hyperaldosteronism?. World J Surg 2014; 38 (07) 1749-1754
• 11 Coresh J, Turin TC, Matsushita K. , et al; CKD Prognosis Consortium. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; 311 (24) 2518-2531
• 12 Nwariaku FE, Miller BS, Auchus R. , et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006; 141 (05) 497-502 , discussion 502–503
• 13 Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136 (06) 1227-1235
• 14 Rossi GP, Sacchetto A, Chiesura-Corona M. , et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001; 86 (03) 1083-1090
• 15 Graham UM, Ellis PK, Hunter SJ, Leslie H, Mullan KR, Atkinson AB. 100 cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and potassium outcomes. Clin Endocrinol (Oxf) 2012; 76 (01) 26-32
• 16 Waldmann J, Maurer L, Holler J. , et al. Outcome of surgery for primary hyperaldosteronism. World J Surg 2011; 35 (11) 2422-2427
• 17 Wu VC, Kuo CC, Wang SM. , et al; TAIPAI Study Group. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens 2011; 29 (09) 1778-1786
• 18 Horita Y, Inenaga T, Nakahama H. , et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis 2001; 37 (05) 884-889
• 19 Fourkiotis V, Vonend O, Diederich S. , et al; Mephisto Study Group. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. Eur J Endocrinol 2012; 168 (01) 75-81
• 20 Iwakura Y, Morimoto R, Kudo M. , et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab 2014; 99 (05) 1593-1598
• 21 Turchi F, Ronconi V, di Tizio V, Ceccoli L, Boscaro M, Giacchetti G. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Nutr Metab Cardiovasc Dis 2014; 24 (05) 476-482
• 22 Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008; 19 (03) 88-90
• 23 Wachtel H, Cerullo I, Bartlett EK. , et al. Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism. Surgery 2014; 156 (06) 1394-1402 , n1402–n1403
• 24 Utsumi T, Kamiya N, Endo T. , et al. Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg 2014; 38 (10) 2640-2644
• 25 Zarnegar R, Young Jr WF, Lee J. , et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 2008; 247 (03) 511-518
• 26 Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40 (06) 892-896
• 27 Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996; 131 (06) 646-650